Multiple chemical sensitivity (MCS) has become a serious problem as a result of airtight techniques in modern construction. The mechanism of the MCS, however, has not been clarified. Responsible chemicals and their exposure levels for patient's hypersensitive reactions need to be identified. We measured the exposure of 15 MCS patients to both carbonyl compounds and volatile organic compounds (VOCs) that may induce hypersensitive reactions. The exposures of those not suffering from MCS (non-MCS individuals) were also measured at the same time. To characterize the chemicals responsible for MCS symptoms, we applied a new sampling strategy for the measurement of carbonyls and VOCs using active and passive sampling methods. The results of our study clearly demonstrated that the chemicals responsible for such hypersensitive reactions varied from patient to patient. Moreover, the concentrations during hypersensitive symptoms, which were apparent in some of the MCS patients, were far below both the WHO and the Japanese indoor guidelines. The average exposure levels of MCS patients within a 7-day period were lower than those of paired non-MCS individuals except for a few patients who were exposed to chemicals in their work places. This result indicates that the MCS patients try to keep away from exposures to the chemical compounds that cause some symptoms.
Introduction
Multiple chemical sensitivity (MCS) is a multiorgan hypersensitivity caused even by small amounts of chemical exposure that is generally considered nontoxic for non-MCS individuals. The initiation of MCS is known to be due to repeated exposures to chemicals (Cullen, 1987) . Once a person acquires MCS, other chemicals as well as some specific chemicals that initiated MCS can trigger the hypersensitive symptoms even at low concentrations (Cullen, 1987) . The hypersensitive reactions include memory difficulty, irritation of the respiratory tract, depression, headache, joint pain, muscle pain, fatigue, nausea, dizziness, and so on (Miller, 1994; Miller and Mitzel, 1995; Davidoff and Keyl, 1996) .
Neutralization (Rea, 1997) , analyses of blood constituents (Gallant, 1987) , eye movement test and electro-pupillography (Shirakawa and Rea, 1991; Kikuchi et al., 2000) have been proposed as diagnostic methods for MCS. The mechanisms of MCS induction are, however, still unknown, especially the levels of substance responsible for the induction of symptoms. Many methods have been attempted to elucidate these mechanisms. The environments, in which the hypersensitive symptoms of MCS patients were induced, were surveyed using questionnaires and consultations (Davidoff and Keyl, 1996; Meggs et al., 1996) . Kostiainen (1995) reported that the concentrations of VOCs in sick houses, in which residents complained about odors or symptoms, were higher than those in the normal house, in which people do not have sickness. Wargocki et al. (1999) reported that air pollution from carpet elevate sick building syndrome symptoms and decreased office productivity, although the concentrations of 41 kinds of volatile organic compounds (VOCs) were much less than the odor threshold. To our knowledge, no study has been conducted to monitor the personal exposures to organic chemicals in MCS patients diagnosed medically. Measurement of the personal exposures to organic compounds in MCS patients could reveal a causal relationship between exposures and the hypersensitive reactions.
The causative chemicals and their concentrations could be quantified by clean room tests (challenge test or neutralization test), because the test can be carried out without the masking. We do not, however, know which substance and levels should be tried on these tests. Identification and semiquantification of the suspected chemicals responsible for symptom development is essential for effective diagnosis as well as the patient's safety. For the purpose of the screening, we developed a new sampling strategy of simultaneous use of the active sampling (AS) and passive sampling (PS) methods to clarify the relationship between personal exposure to carbonyl compounds and hypersensitive reactions (Shinohara and Yanagisawa, accepted) .
In this study, we measured not only carbonyl but also VOCs because VOCs, some of which are toxic, are often detected in the indoor environment. In addition to identification and quantification of the responsible chemicals, we compared the average personal exposures between MCS patients and nonpatients who lived in a similar environment, that is, housemates or neighbors, at the same time to characterize the patients' inhalation environment.
Method

Sampling Strategy
To characterize the responsible chemicals for hypersensitive reactions, the new sampling methodology using the AS and PS methods was developed for measurement of carbonyl compounds and VOCs. MCS patients were asked to carry a pump with two cartridges (Figure 1a ) for carbonyl compounds and VOCs for the AS method and two passive samplers (Figure 1b) , without a pump, for the PS method for 1 week. The patients were asked to turn on the pump at the moment hypersensitive symptoms appeared and to switch it off when the symptoms disappeared. Concentrations obtained by the AS method could essentially represent levels of chemical exposure during which the patients felt hypersensitive reactions, while concentrations by the PS method indicate average personal exposure during the entire sampling period mostly without symptoms. If the concentrations of some particular compounds were higher in the AS method than in the PS method, those compounds are suspected as responsible chemicals for the hypersensitive reactions. As schematically shown in Figure 2 , for example, compound A is likely a causative chemical of the hypersensitive symptoms because its concentration by the AS method is higher than that by the PS method, while compound B is unlikely to be the responsible chemical at this concentration because that by the PS method is higher than that by the AS method.
For the AS method, we used a portable pump (AirCheck2000, SKC Ltd., USA) and needle valve (224-26-02, SKC Ltd., USA) to control flow rates of the air sampling for carbonyl and VOC sampling cartridges. Flow rates of the pump were set at approximately 350 ml/min for carbonyl compounds and 650 ml/min for VOCs, by adjusting the needle valve. Flow rates were measured five times each before and after the survey by bubble meter to ensure stability of the pumps. The average flow rates of these measurements, that is, five times for each of before-and after-measurements, were used for the concentration calculation. If the fluctuation of the flow rates was more than 10%, those samples were not subjected to analyses (US EPA, 1999) . Each sampling cartridge was stored in an aluminum bag at 41C immediately after the sampling until chemical analyses were performed. Subjects were also asked to record their symptoms, activities, and places for the period they had the hypersensitive symptoms in a diary. For the same period, the non-MCS individuals, housemates, or neighbors of MSC patients were asked to carry the two passive samplers for comparison. Samplings were undertaken in 2000 and 2001.
Analytical Method
For the sampling of carbonyl compounds (formaldehyde, acetaldehyde, and acetone), 2,4-dinitrophenyl-hydrazine (DNPH) cartridge (XPoSure Aldehyde Sampler, Waters Ltd., USA) was used, while a charcoal tube (Shibata Scientific Technology Ltd., Japan) was used for VOCs. Target VOCs are chloroform, 2,4-dimethyl-pentane, 1,2-dichloroethane, 2,2,4-trimethylpentane, 1,2-dichloropropane, heptane, trichloroethylene, chlorodibromomethane, octane, tetrachloroethylene, 1,3,5-trimethylbenzene, 1,2,4-trimethylbenzene, 1,2,3-trimethylbenzene, butanol, ethyl acetate, 1,1,1-trichloroethane, benzene, toluene, butyl acetate, ethylbenzene, m/p-xylene, styrene, o-xylene, p-dichlorobenzene, a-pinene, decane, undecane, nonanal, 1,2,4,5-tetramethylbenzene, dodecane, tridecane, tetradecane, pentadecane, and hexadecane.
The carbonyl DNPH derivatives (carbonyl-DNPH) were extracted by 10-ml acetonitrile (HPLC grade, Wako Pure Chemicals Co. Ltd., Japan) from the cartridge. The carbonyl-DNPH derivatives were analyzed by a highperformance liquid chromatography (HPLC, HP1100, Hewlett-Packard Co., USA) with a photo diode array detector. XDB-C18 packed column (ZORBAX Eclipse; 250 mm Â 4.6 mm ID; particle size 5 mm) was used for the separation of the carbonyl-DNPH derivatives. Other specifications are shown in Table 1 . VOCs were extracted by ultrasonication from the charcoal for 10 min in 1 ml carbon disulfide (Wako Pure Chemicals Co. Ltd., Japan). VOCs were analyzed by a gas chromatography-mass spectrometry (GC-MS, HP6890-HP5973, Hewlett-Packard Co., USA). HP5-MS capillary column (Hewlett-Packard Co.; 30 m Â 0.25 mm ID; film thickness 0.25 mm) was used for the separation of VOCs. Other specifications are shown in Table 1 .
Quality control and quality assurance, that is, lower limit of determination (LLD), break-through, recovery efficiency, and reproducibility, as well as uptake rates for PS were determined ( Table 2 ). The data of carbonyls were recapitulated from a previous study (Shinohara and Yanagisawa, accepted) .
Selection of MCS Patients
The subject patients were diagnosed to have MCS at the Kitasato Institute Hospital based on eye movement aberrations and the reaction of their pupils to light (Shirakawa and Rea, 1991; Kikuchi et al., 2000; Bolla, 2000) . In all, 15 MCS patients (A-1, A-2, A-3, A-4, A-5, B, C, D, E-1, E-2, F, G, H, I, and J) and 12 non-MCS individuals (
0 , and J 0 ) voluntarily participated in this survey after giving informed consent. The same alphabet for the subject's ID indicates that the subjects were from the same household. Five patients of the family A participated in the survey three times. Characteristics of these subjects including age, sex, and occupation are summarized in Table 3 .
Results and discussion
The major symptoms that the patients showed during the survey period included headache (N ¼ 9) and nausea (N ¼ 5), while dizziness, eye irritation, depression, asthma, throat pain, foot pain, and shortness of breath were occasionally observed. The detailed information is shown in Table 4 . These MCS symptoms were similar to those described in previous studies (Miller, 1994; Miller and Mitzel, 1995; Davidoff and Keyl, 1996) . For some patients, the symptoms were induced when they stayed in closed rooms (A-1, A-5, C, E-1, E-2, I, J) and/or when they opened doors of closet or hovel (A-3, A-4, C, G, I).
The possible causative chemicals for each patient, the levels of which obtained by the AS method were higher than that by the PS method, are listed in Table 5 . We conservatively defined that a compound is likely to be causative at the level when the following condition is satisfied.
where C AS is the exposure level estimated by the AS method (ppb), RSD AS is the relative standard deviation (RSD) of repeatability test in the AS method (%), C PS is the exposure level estimated by the PS method (ppb), and RSD PS is the RSD of repeatability test in the PS method (%). According to the results, the suspected levels of toluene in 11 patients' symptoms were in the range of 6.31-770 mg/m 3 , while that of acetaldehyde to six patients were within the levels of 6.16-30.7 ppb. The suspected levels of formaldehyde to eight patients were in the range of 11.9-136 ppb, and p-dichlorobenzene to five patients were within the concentrations of 67.5-314 mg/m 3 , among 15 patients of this survey. These chemicals are known to be commonly used in building materials. According to their questionnaires, some occupants used mothballs, a source of p-dichlorobenzene, in their house, which might be responsible for the MCS symptoms based on the results of the AS/PS sampling methods. It was found that the concentrations inducing hypersensitive reactions to some MCS patients were far below the WHO indoor guideline (80 ppb for formaldehyde, 260 mg/m 3 for toluene, and 870 mg/m 3 for xylene). Our research has determined the chemicals that induced hypersensitive reactions to MCS patients and their concentrations were different from one patient to another. For example, exposure to formaldehyde without any symptoms was 61.2 ppb for patient B, while patient F showed the symptoms even at 11.9 ppb. Thus, it is difficult to determine the responsible chemicals and their concentration levels inducing the symptoms in all the patients universally applied.
It is known that the total VOCs (TVOCs) level has an association with odor and nasal pungency (Otto et al., 1990; Molhave, 1991) . To investigate the possible relationship between TVOCs and induction of MCS symptoms, the personal exposure to TVOCs obtained by the AS method were compared with those obtained by the PS method. In this study, TVOCs were defined as all detected chemicals by HPLC and GC-MS. The unknown chemicals were quantified as formaldehyde equivalent for those detected by HPLC, and toluene equivalent for those by GC-MS. The personal exposure to TVOCs was found to be of significantly higher levels in the PS method than in the AS method in many cases (B, F, and J). Therefore, whether TVOCs can induce hypersensitive symptoms to all the patients universally could not be determined.
The hypersensitive symptoms of patient A-1 (female, 43 years old) were due to exposures to formaldehyde (40.9 ppb), acetaldehyde (6.16 ppb), toluene (73.6 mg/m 3 ), p-dichlorobenzene (314 mg/m 3 ), and limonene (18.9 mg/m 3 ) in the first survey (Figure 3a) , while in the third survey they were due to exposure to acetaldehyde (8.09 ppb), ethylbenzene (20.1 mg/ m 3 ), m/p-xylene (48.2 mg/m 3 ), and 1,3,5-trimethylbenzene (27.3 mg/m 3 ) (Figure 3b ). Since this subject did not had hypersensitive symptoms at 331 mg/m 3 of limonene (determined by the PS method) in the third survey, we interpreted that limonene at the level of 18.9 mg/m 3 in the first survey was not causative for her hypersensitive symptoms. This indicated that repeated monitoring using this AS/PS method is necessary to narrow down the responsible chemicals for their hypersensitive symptoms.
The weekly average of personal exposures of the MCS patients were lower than those of paired non-MCS individuals except for some patients (B, F, and I), who were exposed to the chemicals in their workplaces. The average levels of personal exposure of MCS patients surveyed in this study were also lower than those of the normal Japanese reported by Japanese Ministry of Health and Welfare (1999) . This indicates that the MCS patients seem to keep away from exposures to the chemical compounds that may cause their symptoms.
In this study, the number of target chemicals is limited, although there are more than hundred kinds of volatile chemicals in indoor air (Jensen et al., 2001) . Many kinds of untargeted VOCs, however, could be captured by the charcoal tube and quantified as toluene equivalents by the GC-MS. Therefore, the exposure levels of many kinds of untargeted VOCs were also evaluated as toluene equivalents. The responsible levels of the chemicals cannot be determined when the trapped amount by the AS method is below the detection limit. This is a potential limitation of this methodology. The LLD were much lower than the odor threshold levels. In addition, the LLD were also lower than the levels at which general people felt sick building syndrome symptoms.
The present AS/PS method can indentify the responsible chemicals. To prove that the chemicals and levels are responsible for the hypersensitive reactions, a challenge test should be performed after screening by the present AS/PS method. This method is an effective screening method without burdens to subjects.
Conclusions
The responsible chemicals and their concentrations causing hypersensitive reactions in 15 MCS patients were identified and quantified by simultaneous use of the AS and PS methods. The chemicals that induce hypersensitive reactions to MCS patients and their concentrations were different from one to another. The MCS patients developed hypersensitive symptoms at far lower concentrations than some guideline values. Based on the comparison of average personal exposure between MCS patients and non-MCS individuals living in a similar environment, we found that MCS patients seemed to avoid exposures to the causative chemical compounds.
